Bioharvest Sciences Income Statement (2023-2025) | BHST

Income Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 2.75M3.24M4.52M5.34M6.03M6.54M7.28M7.86M8.52M9.07M
Cost of Revenue 1.64M1.80M2.94M2.56M2.81M3.42M2.94M3.68M3.99M4.12M
Gross Profit 1.11M1.44M2.29M3.00M3.10M3.71M4.12M4.59M5.09M5.57M
Operating items
Research & Development 0.81M0.89M1.05M1.03M1.09M1.28M1.40M1.25M1.34M1.43M
Share-based Compensation (IS) 0.13M0.20M0.13M0.15M0.13M0.18M0.13M
Selling, General & Administrative 1.32M0.76M1.53M0.83M0.98M1.12M1.47M1.39M1.58M0.94M
Other Operating Expenses 1.85M1.80M-28.94M-6.29M-6.94M-8.21M-8.68M-8.95M-9.81M-8.86M
Operating Expenses 3.98M3.45M-26.36M-4.43M-4.88M-5.82M-5.81M-6.31M-6.90M-6.49M
Operating Income 2.88M2.01M-17.38M-1.42M-1.78M-2.10M-1.69M-1.72M-1.81M-0.92M
EBIT 2.88M2.01M-17.38M-1.42M-1.78M-2.10M-1.69M-1.72M-1.81M-0.92M
Non-operating items
Other Non Operating Income -0.18M-0.43M2.57M0.07M-1.47M0.34M0.53M0.30M1.62M1.53M
Non Operating Income -0.05M0.31M
Net income details
EBT 2.85M1.73M7.24M-6.58M-0.69M-2.69M-2.95M-2.30M-4.04M-2.45M
Tax Provisions 0.04M0.04M0.06M
Profit After Tax 2.85M1.73M7.24M6.58M0.69M2.69M7.24M2.34M4.08M2.51M
Income from Continuing Operations 2.85M1.73M7.24M-6.58M-0.69M-2.69M-2.95M-2.34M-4.08M-2.51M
Consolidated Net Income 2.85M1.73M7.24M-6.58M-0.69M-2.69M-2.95M-2.34M-4.08M-2.51M
Income towards Parent Company 2.85M1.73M7.24M-6.58M-0.69M-2.69M-2.95M-2.34M-4.08M-2.51M
Net Income towards Common Stockholders 2.85M1.73M7.24M-6.58M-0.69M-2.69M-2.95M-2.34M-4.08M-2.51M
Additional items
EPS (Basic) 0.00M0.53-0.01M-0.04-0.16-0.18-0.13-0.24-0.14
Shares Outstanding (Weighted Average) 400.0013.53M480.0016.35M17.34M16.19M17.33M17.33M17.42M
EBITDA 2.88M2.01M-17.38M-1.42M-1.78M-2.10M-1.69M-1.72M-1.81M-0.92M
Interest Expenses 0.16M0.15M2.17M5.16M0.38M0.59M1.26M0.58M2.23M1.53M
Tax Rate -1.65%-0.97%-2.57%